A citation-based method for searching scientific literature

Abdul K Siraj, Rong Bu, Kaleem Iqbal, Nabil Siraj, Wael Al-Haqawi, Ismail A Al-Badawi, Sandeep Kumar Parvathareddy, Tariq Masoodi, Asma Tulbah, Fouad Al-Dayel, Khawla S Al-Kuraya. Hum Mutat 2019
Times Cited: 2







List of co-cited articles
131 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The epidemiology of cancer in the United Arab Emirates: A systematic review.
Hadia Radwan, Hayder Hasan, Rami A Ballout, Rana Rizk. Medicine (Baltimore) 2018
5
100

Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.
Gordon Fehringer, Peter Kraft, Paul D Pharoah, Rosalind A Eeles, Nilanjan Chatterjee, Fredrick R Schumacher, Joellen M Schildkraut, Sara Lindström, Paul Brennan, Heike Bickeböller,[...]. Cancer Res 2016
59
100

Cancer Genetic Counseling and Testing in an Era of Rapid Change.
Gillian W Hooker, Keelia Rhoads Clemens, John Quillin, Kristen J Vogel Postula, Pia Summerour, Rebecca Nagy, Adam H Buchanan. J Genet Couns 2017
24
100

Incidence, survival, pathology, and genetics of adult Latino Americans with glioblastoma.
Maryam Shabihkhani, Donatello Telesca, Masoud Movassaghi, Yalda B Naeini, Kourosh M Naeini, Seyed Amin Hojat, Diviya Gupta, Gregory M Lucey, Michael Ontiveros, Michael W Wang,[...]. J Neurooncol 2017
21
100

Molecular basis of HNPCC: mutations of MMR genes.
N Papadopoulos, A Lindblom. Hum Mutat 1997
144
100

Molecular genetics of radiographically defined de novo glioblastoma multiforme.
A Tortosa, Y Ino, N Odell, S Swilley, H Sasaki, D N Louis, J W Henson. Neuropathol Appl Neurobiol 2000
16
100

A role for genetic counsellors and clinical geneticists in pharmacogenetics?
W G Newman, B F Murphy, A Callard, K Payne. Clin Genet 2012
6
100




Colorectal cancer among Arab-Israeli women--possible reasons for increased incidence and mortality.
Tova Rainis, Lina Halloun, Dean Keren, Itay Shuv-ami, Alexandra Lavy. J Gastrointest Cancer 2010
4
100

Identification of a novel germline SPOP mutation in a family with hereditary prostate cancer.
Kimberly A Zuhlke, Anna M Johnson, Scott A Tomlins, Nallasivam Palanisamy, John D Carpten, Ethan M Lange, William B Isaacs, Kathleen A Cooney. Prostate 2014
11
100

Androgen receptor CAG repeat length and TMPRSS2:ETS prostate cancer risk: results From the Prostate Cancer Prevention Trial.
William D Figg, Cindy H Chau, Douglas K Price, Cathee Till, Phyllis J Goodman, Yonggon Cho, Marileila Varella-Garcia, Juergen K V Reichardt, Catherine M Tangen, Robin J Leach,[...]. Urology 2014
7
100


Germline mutations in APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis.
M Nielsen, F J Hes, F M Nagengast, M M Weiss, E M Mathus-Vliegen, H Morreau, M H Breuning, J T Wijnen, C M J Tops, H F A Vasen. Clin Genet 2007
97
100

Genetics: United colors of glioblastoma.
M Teresa Villanueva. Nat Rev Clin Oncol 2012
2
100

Known susceptibility SNPs for sporadic prostate cancer show a similar association with "hereditary" prostate cancer.
Ruben G Cremers, Tessel E Galesloot, Katja K Aben, Inge M van Oort, Hans F Vasen, Sita H Vermeulen, Lambertus A Kiemeney. Prostate 2015
8
100

BRCA1 and BRCA2 mutations in ethnic Lebanese Arab women with high hereditary risk breast cancer.
Nagi S El Saghir, Nathalie K Zgheib, Hussein A Assi, Katia E Khoury, Yannick Bidet, Sara M Jaber, Raghid N Charara, Rania A Farhat, Firas Y Kreidieh, Stephanie Decousus,[...]. Oncologist 2015
31
100

Juvenile polyposis syndrome, SMAD4 mutations, and hereditary hemorrhagic telangiectasia.
Frank Schwenter, Felix Ratjen, Terri Berk, Steve Gallinger, Rob Gryfe, Abigail B Gradinger, Marie E Faughnan, Carol A Durno. J Pediatr Gastroenterol Nutr 2012
8
100


MLH1 and MSH2 mutation screening in HNPCC families of Hungary - Two new MMR gene mutations.
M Tanyi, J Olasz, J L Tanyi, L Tóth, P Antal-Szalmás, Z Ress, T Bubán, K Palatka, C András, H Urbancsek,[...]. Eur J Surg Oncol 2014
5
100



Analysis of CHEK2 gene for ovarian cancer susceptibility.
Bora E Baysal, Julie A DeLoia, Joan E Willett-Brozick, Marc T Goodman, Mark F Brady, Francesmary Modugno, Henry T Lynch, Yvette P Conley, Patrice Watson, Holly H Gallion. Gynecol Oncol 2004
27
100


Screening SMAD1, SMAD2, SMAD3, and SMAD5 for germline mutations in juvenile polyposis syndrome.
S Bevan, K Woodford-Richens, P Rozen, C Eng, J Young, M Dunlop, K Neale, R Phillips, D Markie, M Rodriguez-Bigas,[...]. Gut 1999
49
100

Risk Perception and Psychological Distress in Genetic Counselling for Hereditary Breast and/or Ovarian Cancer.
G Cicero, R De Luca, P Dorangricchia, G Lo Coco, C Guarnaccia, D Fanale, V Calò, A Russo. J Genet Couns 2017
19
100

Distribution of hemoglobinopathy disorders in Saudi Arabia based on data from the premarital screening and genetic counseling program, 2011-2015.
Eman S Alsaeed, Ghada N Farhat, Abdullah M Assiri, Ziad Memish, Elawad M Ahmed, Mohammad Y Saeedi, Mishal F Al-Dossary, Hisham Bashawri. J Epidemiol Glob Health 2018
20
100

The association between race and survival in glioblastoma patients in the US: A retrospective cohort study.
Andrew Bohn, Alexander Braley, Pura Rodriguez de la Vega, Juan Carlos Zevallos, Noël C Barengo. PLoS One 2018
22
100

Molecular mechanisms involving prostate cancer racial disparity.
David Hatcher, Garrett Daniels, Iman Osman, Peng Lee. Am J Transl Res 2009
30
100

Genetics: New paediatric glioblastoma treatment option.
Lisa Hutchinson. Nat Rev Clin Oncol 2017
3
100

High prevalence of deleterious BRCA1 and BRCA2 germline mutations in arab breast and ovarian cancer patients.
Al-Joharah Alhuqail, Areej Alzahrani, Hannah Almubarak, Sarah Al-Qadheeb, Lamyaa Alghofaili, Nisreen Almoghrabi, Hamed Alhussaini, Ben Ho Park, Dilek Colak, Bedri Karakas. Breast Cancer Res Treat 2018
13
100

Cancer predisposing BARD1 mutations in breast-ovarian cancer families.
Magdalena Ratajska, Ewelina Antoszewska, Anna Piskorz, Izabela Brozek, Åke Borg, Hanna Kusmierek, Wojciech Biernat, Janusz Limon. Breast Cancer Res Treat 2012
60
100

Cancer predisposing BARD1 mutations affect exon skipping and are associated with overexpression of specific BARD1 isoforms.
Magdalena Ratajska, Magdalena Matusiak, Alina Kuzniacka, Bartosz Wasag, Izabela Brozek, Wojciech Biernat, Magdalena Koczkowska, Jaroslaw Debniak, Marcin Sniadecki, Piotr Kozlowski,[...]. Oncol Rep 2015
15
100

Germline mutations in RAD51D confer susceptibility to ovarian cancer.
Chey Loveday, Clare Turnbull, Emma Ramsay, Deborah Hughes, Elise Ruark, Jessica R Frankum, Georgina Bowden, Bolot Kalmyrzaev, Margaret Warren-Perry, Katie Snape,[...]. Nat Genet 2011
310
100

Low prevalence of loss of heterozygosity and SMAD4 mutations in sporadic and familial juvenile polyposis syndrome-associated juvenile polyps.
Franz Fogt, Charlotte A Brown, Kamrari Badizadegan, Robert L Zimmerman, Robert Odze. Am J Gastroenterol 2004
8
100

The clinical phenotype of hereditary versus sporadic prostate cancer: HPC definition revisited.
Ruben G Cremers, Katja K Aben, Inge M van Oort, J P Michiel Sedelaar, Hans F Vasen, Sita H Vermeulen, Lambertus A Kiemeney. Prostate 2016
6
100

Olaparib combined with abiraterone in patients with metastatic castration-resistant prostate cancer: a randomised, double-blind, placebo-controlled, phase 2 trial.
Noel Clarke, Pawel Wiechno, Boris Alekseev, Nuria Sala, Robert Jones, Ivo Kocak, Vincenzo Emanuele Chiuri, Jacek Jassem, Aude Fléchon, Charles Redfern,[...]. Lancet Oncol 2018
130
100

Hereditary cancer syndromes.
Nils Rahner, Verena Steinke. Dtsch Arztebl Int 2008
24
100

Mutations in DPC4 (SMAD4) cause juvenile polyposis syndrome, but only account for a minority of cases.
R Houlston, S Bevan, A Williams, J Young, M Dunlop, P Rozen, C Eng, D Markie, K Woodford-Richens, M A Rodriguez-Bigas,[...]. Hum Mol Genet 1998
103
100

Training Genetic Counsellors to Deliver an Innovative Therapeutic Intervention: their Views and Experience of Facilitating Multi-Family Discussion Groups.
Ivan Eisler, Frances Flinter, Jo Grey, Suzanne Hutchison, Carole Jackson, Louise Longworth, Rhona MacLeod, Marion McAllister, Alison Metcalfe, Christine Patch,[...]. J Genet Couns 2017
12
100

hMSH2 is the most commonly mutated MMR gene in a cohort of Greek HNPCC patients.
A Apessos, M Mihalatos, I Danielidis, G Kallimanis, N J Agnantis, J K Triantafillidis, G Fountzilas, P A Kosmidis, E Razis, V A Georgoulias,[...]. Br J Cancer 2005
16
100


Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.
Roel G W Verhaak, Katherine A Hoadley, Elizabeth Purdom, Victoria Wang, Yuan Qi, Matthew D Wilkerson, C Ryan Miller, Li Ding, Todd Golub, Jill P Mesirov,[...]. Cancer Cell 2010
100

Genetic causes of cancer predisposition in children and adolescents.
Federica Saletta, Luciano Dalla Pozza, Jennifer A Byrne. Transl Pediatr 2015
16
100

Whole genome sequence analysis links chromothripsis to EGFR, MDM2, MDM4, and CDK4 amplification in glioblastoma.
John M Furgason, Robert F Koncar, Sharon K Michelhaugh, Fazlul H Sarkar, Sandeep Mittal, Andrew E Sloan, Jill S Barnholtz-Sloan, El Mustapha Bahassi. Oncoscience 2015
35
100

[Genetic profiling in the diagnosis of hereditary prostate cancer: Where do we stand?]
Katharina Boehm, Christian Thomas, Igor Tsaur. Aktuelle Urol 2018
2
100





Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.